神经内镜血肿清除术治疗成人慢性硬膜下血肿的临床疗效

doi:10.3969/j.issn.1671-7171.2024.10.026

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1250 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To investigate the clinical effect of neuroendoscopic hematoma removal in the treatment of chronic subdural hematoma (CSDH) in adults. 【Methods】 The clinical data of 80 adult patients with CSDH admitted to our hospital from June 2021 to June 2023 were retrospectively analyzed. According to different treatment methods, the patients were divided into the control group (irrigation and drainage of single-pore hematoma via parietal tuberculum, n=38) and the observation group (removal of subdural hematoma by neuroendoscopy, n=42). The modified Rankin Scale (mRS) and Barthel index (BI) were used to evaluate the neurological function and daily living ability of the patients before and after surgery, and the length of hospital stay and recurrence rate of the two groups were compared. 【Results】Before operation, there was no statistical significance in the distribution of mRS Scores between the two groups (P>0.05). After operation, the improvement of mRS Score in the observation group was significantly better than that in the control group, and the difference was statistically significant (P<0.05). Before operation, there was no significant difference in BI index classification between the two groups (P>0.05). After operation, BI index improvement in the observation group was significantly better than that in the control group, and the difference was statistically significant (P<0.05). The duration of hospitalization in the observation group was shorter than that in the control group, and the postoperative recurrence rate was lower than that in the control group, the difference was statistically significant (P<0.05).【Conclusion】Neuroendoscopic surgery can better improve the neurological function and daily living ability of patients, shorten the length of hospital stay, and have a lower postoperative recurrence rate, which has high clinical application value.

Key words： Hematoma, Subdural, Chronic/SU Hematoma/SU Neuroendoscopy Treatment Outcome

Received: 13 October 2023

PACS:

R743.34

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2024.10.026 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2024/V41/I10/1547

[1] 张华军,齐文涛,庄国权,等.非外伤性与外伤性慢性硬膜下血肿的临床特征分析[J].中国临床神经外科杂志, 2022, 27(12):989-991.
[2] 刘振生,曹德茂,孙勇,等.脑膜中动脉栓塞与传统方法治疗慢性硬膜下血肿疗效的倾向性评分匹配对比研究[J].中华放射学杂志, 2022, 56(6):661-666.
[3] 沙小松,吴楚伟,高杰,等.单侧慢性硬膜下血肿单孔与双孔钻孔引流术的疗效对比分析[J].中华神经外科杂志, 2024, 40(6):591-595.
[4] 崔敏,唐小勇,邓永兵,等.分隔型慢性硬膜下血肿不同手术方式疗效及复发危险因素分析[J].第三军医大学学报, 2022(2):44.
[5] 荣波,袁致海,王凤鹿,等.神经内镜手术治疗慢性硬膜下血肿的应用进展[J].中国临床神经外科杂志, 2022, 27(10):866-868.
[6] 钱辉,黄华,夏家杰,等.神经内镜手术治疗慢性硬膜下血肿的疗效观察[J].浙江创伤外科, 2023, 28(11):2030-2033.
[7] 梁庆新,郭斯荣,邓玉婷,等.软性神经内镜辅助治疗慢性硬膜下血肿的效果及安全性分析[J].中国医药导刊,2022,24(7):683-686.
[8] 张蕾,侯梅英,程刚,等.钻孔尿激酶注入引流联合阿托伐他汀钙治疗慢性硬膜下血肿的临床研究[J].中国现代手术学杂志,2017,23(5):398-401.
[9] 胡凯,张华.慢性硬膜下血肿发病机制及治疗的研究进展[J].临床神经外科杂志,2024,21(1):102-105.
[10] 张成,李良.慢性硬膜下血肿的病理机制及治疗进展[J].中国微创外科杂志,2023,23(4):317-320.
[11] 周祝青,周兰,庄倩.老年慢性硬膜下血肿病人钻孔引流术后谵妄风险评估体系的建立[J].全科护理,2024,22(11):2154-2157.
[12] 姚远,魏晓明,杨雄,等.神经内镜手术清除慢性硬膜下血肿的疗效[J].中国临床神经外科杂志,2022,27(7):589-590.
[13] 张笑,银锐,李鹏涛,等.神经内镜硬膜下血肿清除术与钻孔引流术联合尿激酶治疗分隔型慢性硬膜下血肿疗效对比[J].中国现代神经疾病杂志,2024,24(6):455-460.
[14] MOSER M , COLUCCIA D , WATERMANN C ,et al.Reducing morbidity associated with subdural drain placement after burr-hole drainage of unilateral chronic subdural hematomas: a retrospective series comparing conventional and modified Nelaton catheter techniques[J].Acta Neurochir(Wien),2023,165(11):3207-3215.